
	ParagonRx^® Case Studies

Re-invigorating Growth of a Mature Brand

Accelerating Growth of a Recently Launched Brand

Avoiding Premature Product Withdrawal

Accelerating Growth of a Recently Launched Brand

Market share for an antiretroviral drug indicated for HIV-positive patients was 50% in all regions of the country. In-depth practice assessment revealed that anticipated difficulty in the management of troublesome side effects had become a barrier to greater adoption.

Special tools and peer influence programs were developed to show physicians in a large region of the country how to manage the side effects. Within nine months, market share in this test region improved to 67%, while other regions remained at approximately 50%.

Re-invigorate Growth of a Mature Brand

Avoiding Premature Product Withdrawal

Join Our Newsletter

Keep up to date with events and news pertaining to pharmaceutical risk management and Process of Care^®.

E-mail
Name
		Subscribe
		Unsubscribe


Privacy Statement: ParagonRx^® will NOT sell, distribute, rent or otherwise intentionally share any information you provide to us with any third party without your consent.